Pain Therapeutics (PTIE)
Pain Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of drugs for use in pain management, primarily in the area of opioid painkillers in the United States. Its Phase III clinical trial products include Remoxy, which is an anti-abuse version of long-acting oxycodone; and Oxytrex, which is an opioid painkiller for the treatment of chronic pain. The company has a strategic alliance with King Pharmaceuticals, Inc. for the development and commercialization of Remoxy and other abuse-resistant opioid painkillers. Pain Therapeutics was founded in 1998 and is based in South San Francisco, California.
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer: 
Contact Information:
| Business Address: | 7801 N Capital of Texas Highway, Suite 260, Austin, TX 78731, United States |
| Mailing Address: | - |
| Phone: | 512-501-2444 |
| Fax: | 512-614-0414 |
| Website: | http//www.paintrials.com |
Company Details:
| Symbol: | PTIE |
| SIC: | 2834 |
| State location: | CA |
| Sector: | - |
| State of Inc: | DE |
| Employees: | 27 |
| Type: | - |
Key executives:
| Name | Age | Position |
|---|---|---|
| Grant L. Schoenhard Ph.D. | 72 | Chief Scientific Officer |
| Nadav Friedmann M.D. | 74 | Chief Operating Officer, Chief Medical Officer |
| Peter S. Roddy | 57 | Chief Financial Officer, Principal Accounting Officer and VP |
| Remi Barbier | 57 | Founder, Chairman, Chief Exec. Officer and Pres |
